Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$67,508,019
+$21,841,494 QoQ
Shares Held
265,811
+42.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#382
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. JNJ ranks #2 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,508,019 | 265,811 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $45,666,525 | 186,821 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $53,916,062 | 260,527 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $49,797,136 | 268,564 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $39,081,698 | 255,854 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $37,301,396 | 224,924 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $39,838,037 | 275,467 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,997,542 | 246,807 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $38,662,974 | 264,525 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $39,803,925 | 251,621 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $38,825,281 | 247,705 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $39,491,502 | 253,557 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $41,962,464 | 253,519 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $36,526,060 | 235,652 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $40,026,946 | 226,589 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $23,223,257 | 142,160 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,577,024 | 65,219 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,718,419 | 83,047 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $16,032,338 | 93,718 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $14,296,464 | 88,523 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $9,580,454 | 58,155 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $9,007,201 | 54,805 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $7,970,352 | 50,644 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $8,014,061 | 53,829 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $9,258,376 | 65,835 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,265,661 | 24,904 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||